Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia
POEM
1 other identifier
interventional
20
1 country
1
Brief Summary
This is a pilot study for a new endoscopic treatment of achalasia. Up to 25 patients will be recruited for this trial, with the intent to treat 20 patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 24, 2014
CompletedFirst Posted
Study publicly available on registry
February 27, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedSeptember 27, 2021
September 1, 2021
2.1 years
February 24, 2014
September 21, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Safety and Efficacy of POEM Procedure
To assess adverse events related to POEM
Intraoperative to one year follow-up
Long-term patient-reported quality of life
To assess change in quality of life from baseline, based on validated quality of life measures, at baseline through 1 year follow-up.
Baseline to one year follow-up
Study Arms (1)
Treatment
OTHERPeroral Endoscopic Myotomy (POEM)
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosis of Achalasia
- Age 16-80
- ASA Class 1-3
You may not qualify if:
- Pregnancy
- Any prior surgical or endoscopic treatment for achalasia -- first eight subjects.
- Patients who are taking immunosuppressive medications or are immunocompromised
- Patients on anticoagulant medications or abnormal coagulation tests
- Patients with severe medical comorbidities, in the judgment of the treating surgeon
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kyle M Perry, MD
Ohio State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 24, 2014
First Posted
February 27, 2014
Study Start
August 1, 2012
Primary Completion
September 1, 2014
Study Completion
December 1, 2014
Last Updated
September 27, 2021
Record last verified: 2021-09